UC Irvine Health Cancer Center-Newport — Costa Mesa, California

UC Irvine Health Cancer Center-Newport is a clinical research site located in Costa Mesa, California, United States 92627.

Crixeo Clinical Trials Trust Score: 25/100 (FAILING). This profile has not yet been claimed by the site owner.

UC Irvine Health Cancer Center-Newport has participated in 40 clinical trials with 30 currently active.

Therapeutic areas: Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8, Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome.

Sponsors: National Cancer Institute (NCI), Alliance for Clinical Trials in Oncology, SWOG Cancer Research Network.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Costa Mesa

Browse all research sites in California · View every site in Costa Mesa

Sponsor Feasibility Report

Trust Score: 25/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UC Irvine Health Cancer Center-Newport?

UC Irvine Health Cancer Center-Newport has a Crixeo Trust Score of 25/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UC Irvine Health Cancer Center-Newport conducted?

UC Irvine Health Cancer Center-Newport has 40 clinical trials on record, with 30 currently active. Their work covers Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8, Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome.

Is UC Irvine Health Cancer Center-Newport accredited by Crixeo Clinical Trials?

UC Irvine Health Cancer Center-Newport has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UC Irvine Health Cancer Center-Newport?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.